These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31826699)

  • 1. Twenty years of metabonomics: so what has metabonomics done for toxicology?
    Griffin JL
    Xenobiotica; 2020 Jan; 50(1):110-114. PubMed ID: 31826699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR-based metabolomics.
    Reo NV
    Drug Chem Toxicol; 2002 Nov; 25(4):375-82. PubMed ID: 12378948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal pharmacometabonomics for predicting patient responses to therapy: drug metabolism, toxicity and efficacy.
    Nicholson JK; Everett JR; Lindon JC
    Expert Opin Drug Metab Toxicol; 2012 Feb; 8(2):135-9. PubMed ID: 22248264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabonomics: its potential as a tool in toxicology for safety assessment and data integration.
    Griffin JL; Bollard ME
    Curr Drug Metab; 2004 Oct; 5(5):389-98. PubMed ID: 15544433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Metabonomics Approach to Drug Toxicology in Liver Disease and its Application in Traditional Chinese Medicine.
    Su G; Wang H; Bai J; Chen G; Pei Y
    Curr Drug Metab; 2019; 20(4):292-300. PubMed ID: 30599107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project.
    Lindon JC; Nicholson JK; Holmes E; Antti H; Bollard ME; Keun H; Beckonert O; Ebbels TM; Reily MD; Robertson D; Stevens GJ; Luke P; Breau AP; Cantor GH; Bible RH; Niederhauser U; Senn H; Schlotterbeck G; Sidelmann UG; Laursen SM; Tymiak A; Car BD; Lehman-McKeeman L; Colet JM; Loukaci A; Thomas C
    Toxicol Appl Pharmacol; 2003 Mar; 187(3):137-46. PubMed ID: 12662897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent development of metabonomics and its applications in clinical research].
    Li H; Jiang Y; He FC
    Yi Chuan; 2008 Apr; 30(4):389-99. PubMed ID: 18424407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of metabonomics at the interface between drug metabolism and safety assessment.
    Waters NJ
    Curr Drug Metab; 2010 Oct; 11(8):686-92. PubMed ID: 20973758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacometabonomics in humans: a new tool for personalized medicine.
    Everett JR
    Pharmacogenomics; 2015; 16(7):737-54. PubMed ID: 25929853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacometabonomics: The Prediction of Drug Effects Using Metabolic Profiling.
    Everett JR
    Handb Exp Pharmacol; 2019; 260():263-299. PubMed ID: 31823071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabonomics techniques and applications to pharmaceutical research & development.
    Lindon JC; Holmes E; Nicholson JK
    Pharm Res; 2006 Jun; 23(6):1075-88. PubMed ID: 16715371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabonomics and toxicology.
    Zhao L; Hartung T
    Methods Mol Biol; 2015; 1277():209-31. PubMed ID: 25677156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabonomics: a useful tool for the future surgeon.
    Goldsmith P; Fenton H; Morris-Stiff G; Ahmad N; Fisher J; Prasad KR
    J Surg Res; 2010 May; 160(1):122-32. PubMed ID: 19592031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabonomics for discovering biomarkers of hepatotoxicity and nephrotoxicity.
    Zhang A; Sun H; Wang P; Han Y; Wang X
    Pharmazie; 2012 Feb; 67(2):99-105. PubMed ID: 22512077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis.
    Griffin JL
    Curr Opin Chem Biol; 2003 Oct; 7(5):648-54. PubMed ID: 14580571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabonomic characterization of genetic variations in toxicological and metabolic responses using probabilistic neural networks.
    Holmes E; Nicholson JK; Tranter G
    Chem Res Toxicol; 2001 Feb; 14(2):182-91. PubMed ID: 11258967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabonomics in the preclinical and environmental toxicity field.
    Colet JM
    Drug Discov Today Technol; 2015 Jun; 13():3-10. PubMed ID: 26190677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacometabonomics and personalized medicine.
    Everett JR; Loo RL; Pullen FS
    Ann Clin Biochem; 2013 Nov; 50(Pt 6):523-45. PubMed ID: 23888060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabonomics in pharmaceutical R&D.
    Lindon JC; Holmes E; Nicholson JK
    FEBS J; 2007 Mar; 274(5):1140-51. PubMed ID: 17298438
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.